1. BensonAB3rd, AbramsTA, Ben‐JosefE, et al. NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw2009;7:350.

2. LivraghiT, FestiD, MontiF, et al.US‐guided percutaneous alcohol injection of small hepatic and abdominal tumors. Radiology1986;161:309. CrossRef

3. LivraghiT, GiorgioA, MarinG, et al.Hepatocellular carcinoma and cirrhosis in 746 patients: long‐term results of percutaneous ethanol injection. Radiology1995;197:101. CrossRef

4. KodaM, MurawakiY, MitsudaA, et al.Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma. Cancer2000;88:529. CrossRef

5. GoldbergSN, GazelleGS, MuellerPR. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol2000;174:323. CrossRef

6. LivraghiT, GoldbergSN, LazzaroniS, et al.Small hepatocellular carcinoma: treatment with radio‐frequency ablation versus ethanol injection. Radiology1999;210:655. CrossRef

7. NamSY, RhimH, KangTW, et al.Percutaneous radiofrequency ablation for hepatic tumors abutting the diaphragm: clinical assessment of the heat‐sink effect of artificial ascites. AJR Am J Roentgenol2010;194:W227. CrossRef

8. YuNC, RamanSS, KimYK, et al.Microwave liver ablation: influence of hepatic vein size on heat‐sink effect in a porcine model. J Vasc Interv Radiol2008;19:1087. CrossRef

9. ShiinaS, TateishiR, ImamuraM, et al.Percutaneous ethanol injection for hepatocellular carcinoma: 20‐year outcome and prognostic factors. Liver Int2012;32:1434. CrossRef

10. LencioniR, CioniD, CrocettiL, et al.Early‐stage hepatocellular carcinoma in patients with cirrhosis: long‐term results of percutaneous image‐guided radiofrequency ablation. Radiology2005;234:961. CrossRef

11. PengZ‐W, ZhangY‐J, ChenM‐S, et al.Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. J Clin Oncol2013;31:426. CrossRef

12. RocheA, GirishBV, de BaereT, et al.Trans‐catheter arterial chemoembolization as first‐line treatment for hepatic metastases from endocrine tumors. Eur Radiol2003;13:136.

13. SalhabM, CaneloR. An overview of evidence‐based management of hepatocellular carcinoma: a meta‐analysis. J Cancer Res Ther2011;7:463. CrossRef

14. OttoG, SchuchmannM, Hoppe‐LotichiusM, et al.How to decide about liver transplantation in patients with hepatocellular carcinoma: size and number of lesions or response to TACE?J Hepatol2013;59:279. CrossRef

15. YamadaR, SatoM, KawabataM, et al.Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology1983;148:397. CrossRef

16. TadavarthySM, KnightL, OvittTW, et al.Therapeutic transcatheter arterial embolization. Radiology1974;112:13. CrossRef

17. SalemR, GilbertsenM, ButtZ, et al.Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolization. Clin Gastroenterol Hepatol2013;11:1358. CrossRef

18. SeldingerSI. Catheter replacement of the needle in percutaneous arteriography; a new technique. Acta Radiol1953;39:368. CrossRef

19. RaoulJL, HeresbachD, BretagneJF, et al.Chemoembolization of hepatocellular carcinomas. A study of the biodistribution and pharmacokinetics of doxorubicin. Cancer1992;70:585. CrossRef

20. PleguezueloM, MarelliL, MisseriM, et al.TACE versus TAE as therapy for hepatocellular carcinoma. Expert Rev Anticancer Ther2008;8:1623. CrossRef

21. YumotoY, JinnoK, TokuyamaK, et al.Hepatocellular carcinoma detected by iodized oil. Radiology1985;154:19. CrossRef

22. ChungJW, ParkJH, HanJK, et al.Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization. Radiology1996;198:33. CrossRef

23. BruixJ, ShermanM, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology2011;53:1020. CrossRef

24. SaharaS, KawaiN, SatoM, et al.Prospective evaluation of transcatheter arterial chemoembolization (TACE) with multiple anti‐cancer drugs (Epirubicin, Cisplatin, Mitomycin C, 5‐Fluorouracil) compared with TACE with epirubicin for treatment of hepatocellular carcinoma. Cardiovasc Intervent Radiol2012;35:1363. CrossRef

25. BrownDB, GouldJE, GervaisDA, et al.Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol2009;20(7 Suppl):S425. CrossRef

26. KimYJ, LeeHG, ParkJM, et al.Polyvinyl alcohol embolization adjuvant to oily chemoembolization in advanced hepatocellular carcinoma with arterioportal shunts. Korean J Radiol2007;8:311. CrossRef

27. LaurentA, BeaujeuxR, WassefM, et al.Trisacryl gelatin microspheres for therapeutic embolization, I: development and in vitro evaluation. AJNR Am J Neuroradiol1996;17:533.

28. LammerJ, MalagariK, VoglT, et al.Prospective randomized study of doxorubicin‐eluting‐bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol2010;33:41. CrossRef

29. ReyesDK, VossenJA, KamelIR, et al.Single‐center phase II trial of transarterial chemoembolization with drug‐eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States. Cancer J2009;15:526. CrossRef

30. ConstantinM, FundueanuG, BortolottiF, et al.Preparation and characterisation of poly(vinyl alcohol)/cyclodextrin microspheres as matrix for inclusion and separation of drugs. Int J Pharm2004;285:87. CrossRef

31. QianJ, TruebenbachJ, GraeplerF, et al.Application of poly‐lactide‐co‐glycolide‐microspheres in the transarterial chemoembolization in an animal model of hepatocellular carcinoma. World J Gastroenterol2003;9:94. CrossRef

32. GonzalezMV, TangY, PhillipsGJ, et al.Doxorubicin eluting beads‐2: methods for evaluating drug elution and in‐vitro:in‐vivo correlation. J Mater Sci Mater Med2008;19:767. CrossRef

33. NamurJ, CitronSJ, SellersMT, et al.Embolization of hepatocellular carcinoma with drug‐eluting beads: doxorubicin tissue concentration and distribution in patient liver explants. J Hepatol2011;55:1332. CrossRef

34. SekiA, HoriS, KobayashiK, NarumiyaS. Transcatheter arterial chemoembolization with epirubicin‐loaded superabsorbent polymer microspheres for 135 hepatocellular carcinoma patients: single‐center experience. Cardiovasc Intervent Radiol2011;34:557. CrossRef

35. HataM, TokuuyeK, SugaharaS, et al.Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus. Cancer2005;104:794. CrossRef

36. GeschwindJF, SalemR, CarrBI, et al.Yttrium‐90 microspheres for the treatment of hepatocellular carcinoma. Gastroenterology2004;127(5 Suppl 1):S194. CrossRef

37. SalemR, ThurstonKG. Radioembolization with 90Yttrium microspheres: a state‐of‐the‐art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations. J Vasc Interv Radiol2006;17:1251. CrossRef

38. StrigariL, SciutoR, ReaS, et al.Efficacy and toxicity related to treatment of hepatocellular carcinoma with 90Y‐SIR spheres: radiobiologic considerations. J Nucl Med2010;51:1377. CrossRef

39. Gil‐AlzugarayB, ChopiteaA, IñarrairaeguiM, et al.Prognostic factors and prevention of radioembolization‐induced liver disease. Hepatology2013;57:1078. CrossRef

40. FornerA, LlovetJM, BruixJ. Hepatocellular carcinoma. Lancet2012;379:1245. CrossRef

41. BrownDB, NikolicB, CoveyAM, et al.Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy. J Vasc Interv Radiol2012;23:287. CrossRef

42. HoAS, PicusJ, DarcyMD, et al.Long‐term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors. AJR Am J Roentgenol2007;188:1201. CrossRef

43. BrownDB, CardellaJF, SacksD, et al.Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy. J Vasc Interv Radiol2009;20(7 Suppl):S219, S226 e1‐10. CrossRef

44. SangroB, InarrairaeguiM, BilbaoJI. Radioembolization for hepatocellular carcinoma. J Hepatol2012;56:464. CrossRef

45. GeorgiadesCS, LiapiE, FrangakisC, et al.Prognostic accuracy of 12 liver staging systems in patients with unresectable hepatocellular carcinoma treated with transarterial chemoembolization. J Vasc Interv Radiol2006;17:1619. CrossRef

46. DhandS, GuptaR. Hepatic transcatheter arterial chemoembolization complicated by postembolization syndrome. Semin Interv Radiol2011;28:207. CrossRef

47. BouvierA, OzenneV, AubéC, et al.Transarterial chemoembolisation: effect of selectivity on tolerance, tumor response and survival. Eur Radiol2011;21:1719. CrossRef

48. HongK, KhwajaA, LiapiE, et al.New intra‐arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer. Clin Cancer Res2006;12:2563. CrossRef

49. VarelaM, RealMI, BurrelM, et al.Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol2007;46:474. CrossRef

50. RiazA, LewandowskiRJ, KulikLM, et al.Complications following radioembolization with yttrium‐90 microspheres: a comprehensive literature review. J Vasc Interv Radiol2009;20:1121, quiz 1131. CrossRef

51. SalemR, LewandowskiRJ, AtassiB, et al.Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival. J Vasc Interv Radiol2005;16:1627. CrossRef

52. LewandowskiRJ, MulcahyMF, KulikLM, et al.Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172‐patient cohort. Radiology2010;255:955. CrossRef

53. TakakiS, SakaguchiH, AnaiH, et al.Long‐term outcome of transcatheter subsegmental and segmental arterial chemoemobolization using lipiodol for hepatocellular carcinoma. Cardiovasc Intervent Radiol2012;35:544. CrossRef

54. TerziE, GolfieriR, PiscagliaF, et al.Response rate and clinical outcome of HCC after first and repeated cTACE performed “on demand”.J Hepatol2012;57:1258. CrossRef

55. BurgerI, HongK, SchulickR, et al.Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution. J Vasc Interv Radiol2005;16:353. CrossRef

56. VoglTJ, NaguibNN, Nour‐EldinNE, et al.Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma: Results and prognostic factors governing treatment success. Int J Cancer2012;131:733. CrossRef

57. VoglTJ, Gruber‐RouhT, EichlerK, et al.Repetitive transarterial chemoembolization (TACE) of liver metastases from gastric cancer: local control and survival results. Eur J Radiol2013;82:258. CrossRef

58. AziziA, NaguibNN, MbalisikeE, et al.Liver metastases of pancreatic cancer: role of repetitive transarterial chemoembolization (TACE) on tumor response and survival. Pancreas2011;40:1271. CrossRef

59. MalagariK, PomoniM, MoschourisH, et al.Chemoembolization with doxorubicin‐eluting beads for unresectable hepatocellular carcinoma: five‐year survival analysis. Cardiovasc Intervent Radiol2012;35:1119. CrossRef

60. KuhlmannJB, EuringerW, SpangenbergHC, et al.Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead‐transarterial chemoembolization and systemic chemotherapy. Eur J Gastroenterol Hepatol2012;24:437.

61. NarayananG, BarberyK, SutharR, et al.Transarterial chemoembolization using DEBIRI for treatment of hepatic metastases from colorectal cancer. Anticancer Res2013;33:2077.

62. BhagatN, ReyesDK, LinM, et al.Phase II study of chemoembolization with drug‐eluting beads in patients with hepatic neuroendocrine metastases: high incidence of biliary injury. Cardiovasc Intervent Radiol2013;36:449. CrossRef

63. HilgardP, HamamiM, FoulyAE, et al.Radioembolization with yttrium‐90 glass microspheres in hepatocellular carcinoma: European experience on safety and long‐term survival. Hepatology2010;52:1741. CrossRef

64. SalemR, LewandowskiRJ, MulcahyMF, et al.Radioembolization for hepatocellular carcinoma using Yttrium‐90 microspheres: a comprehensive report of long‐term outcomes. Gastroenterology2010;138:52. CrossRef

65. IbrahimSM, MulcahyMF, LewandowskiRJ, et al.Treatment of unresectable cholangiocarcinoma using yttrium‐90 microspheres: results from a pilot study. Cancer2008;113:2119. CrossRef

66. MouliS, MemonK, BakerT, et al.Yttrium‐90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis. J Vasc Interv Radiol2013;24:1227. CrossRef

67. RafiS, PiduruSM, El‐RayesB, et al.Yttrium‐90 radioembolization for unresectable standard‐chemorefractory intrahepatic cholangiocarcinoma: survival, efficacy, and safety study. Cardiovasc Intervent Radiol2013;36:440. CrossRef

68. MulcahyMF, LewandowskiRJ, IbrahimSM, et al.Radioembolization of colorectal hepatic metastases using yttrium‐90 microspheres. Cancer2009;115:1849. CrossRef

69. CosimelliM, GolfieriR, CagolPP, et al.Multi‐centre phase II clinical trial of yttrium‐90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases. Br J Cancer2010;103:324. CrossRef

70. CianniR, PelleG, NotarianniE, et al.Radioembolisation with (90)Y‐labelled resin microspheres in the treatment of liver metastasis from breast cancer. Eur Radiol2013;23:182. CrossRef

71. LongstrethGF. Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: a population‐based study. Am J Gastroenterol1995;90:206.

72. MauroMA, MurphyKPJ. Image‐Guided Interventions: Expert Radiology Series, 2nd ed. Philadelphia: Saunders; 2013.

73. StrateLL, LowerGI. Bleeding: epidemiology and diagnosis. Gastroenterol Clin North Am2005;34:643. CrossRef

74. SchenkerMP, DuszakRJ, SoulenMC, et al.Upper gastrointestinal hemorrhage and transcatheter embolotherapy: clinical and technical factors impacting success and survival. J Vasc Interv Radiol2001;12:1263. CrossRef

75. PatelTH, CordtsPR, AbcarianP, SawyerMA. Will transcatheter embolotherapy replace surgery in the treatment of gastrointestinal bleeding?(2)(2). Curr Surg2001;58:323. CrossRef

76. AinaR, OlivaVL, TherasseE, et al.Arterial embolotherapy for upper gastrointestinal hemorrhage: outcome assessment. J Vasc Interv Radiol2001;12:195. CrossRef

77. ZuccaroGJr. Management of the adult patient with acute lower gastrointestinal bleeding. American College of Gastroenterology. Practice Parameters Committee. Am J Gastroenterol1998;93:1202. CrossRef

78. BrowderW, CeriseEJ, LitwinMS. Impact of emergency angiography in massive lower gastrointestinal bleeding. Ann Surg1986;204:530. CrossRef

79. PennoyerWP, VignatiPV, CohenJL. Mesenteric angiography for lower gastrointestinal hemorrhage: are there predictors for a positive study?Dis Colon Rectum1997;40:1014. CrossRef

80. KuhleWG, SheimanRG. Detection of active colonic hemorrhage with use of helical CT: findings in a swine model. Radiology2003;228:743. CrossRef

81. AlaviA, RingEJ. Localization of gastrointestinal bleeding: superiority of 99mTc sulfur colloid compared with angiography. AJR Am J Roentgenol1981;137:741. CrossRef

82. SteerML, SilenW. Diagnostic procedures in gastrointestinal hemorrhage. N Engl J Med1983;309:646. CrossRef

83. AbbasSM, BissettIP, HoldenA, et al.Clinical variables associated with positive angiographic localization of lower gastrointestinal bleeding. ANZ J Surg2005;75:953. CrossRef

84. RollinsES, PicusD, HicksME, et al.Angiography is useful in detecting the source of chronic gastrointestinal bleeding of obscure origin. AJR Am J Roentgenol1991;156:385. CrossRef

85. BandiR, ShettyPC, SharmaRP, et al.Superselective arterial embolization for the treatment of lower gastrointestinal hemorrhage. J Vasc Interv Radiol2001;12:1399. CrossRef

86. d'OtheeBJ, SurapaneniP, RabkinD, et al.Microcoil embolization for acute lower gastrointestinal bleeding. Cardiovasc Intervent Radiol2006;29:49. CrossRef

87. DefreyneL, VanlangenhoveP, De VosM, et al.Embolization as a first approach with endoscopically unmanageable acute nonvariceal gastrointestinal hemorrhage. Radiology2001;218:739. CrossRef

88. EvangelistaPT, HalliseyMJ. Transcatheter embolization for acute lower gastrointestinal hemorrhage. J Vasc Interv Radiol2000;11:601. CrossRef

89. FunakiB, KostelicJK, LorenzJ, et al.Superselective microcoil embolization of colonic hemorrhage. AJR Am J Roentgenol2001;177:829. CrossRef

90. BakalCW, SprayregenS, WolfEL. Radiology in intestinal ischemia. Angiographic diagnosis and management. Surg Clin North Am1992;72:125.

91. SreenarasimhaiahJ. Diagnosis and management of intestinal ischaemic disorders. BMJ2003;326:1372. CrossRef

92. SchootsIG, KoffemanGI, LegemateDA, et al.Systematic review of survival after acute mesenteric ischaemia according to disease aetiology. Br J Surg2004;91:17. CrossRef

93. WyersMC. Acute mesenteric ischemia: diagnostic approach and surgical treatment. Semin Vasc Surg2010;23:9. CrossRef

94. CorcosO, CastierY, SibertA, et al.Effects of a multimodal management strategy for acute mesenteric ischemia on survival and intestinal failure. Clin Gastroenterol Hepatol2013;11:158. CrossRef

95. MatsumotoAH, TegtmeyerCJ, FitzcharlesEK, et al.Percutaneous transluminal angioplasty of visceral arterial stenoses: results and long‐term clinical follow‐up. J Vasc Interv Radiol1995;6:165. CrossRef

96. EndeanED, BarnesSL, KwolekCJ, et al.Surgical management of thrombotic acute intestinal ischemia. Ann Surg2001;233:801. CrossRef

97. ParkWM, GloviczkiP, CherryKJJr, et al.Contemporary management of acute mesenteric ischemia: factors associated with survival. J Vasc Surg2002;35:445. CrossRef

98. SchootsIG, LeviMM, ReekersJA, et al.Thrombolytic therapy for acute superior mesenteric artery occlusion. J Vasc Interv Radiol2005;16:317. CrossRef

99. OldenburgWA, LauLL, RodenbergTJ, et al.Acute mesenteric ischemia: a clinical review. Arch Intern Med2004;164:1054. CrossRef

100. JamiesonAC, ThomasRJ, CadeJF. Lysis of a superior mesenteric artery embolus following local infusion of streptokinase and heparin. Aust N Z J Surg1979;49:355. CrossRef

101. HalliseyMJ, DeschaineJ, IllescasFF, et al.Angioplasty for the treatment of visceral ischemia. J Vasc Interv Radiol1995;6:785. CrossRef

102. TytleTL, PratiRCJr. Percutaneous recanalization in chronic occlusion of the superior mesenteric artery. J Vasc Interv Radiol1995;6:133. CrossRef

103. BoyerL, DelormeJM, AlexandreM, et al.Local fibrinolysis for superior mesenteric artery thromboembolism. Cardiovasc Intervent Radiol1994;17:214. CrossRef

104. McKinseyJF, GewertzBL. Acute mesenteric ischemia. Surg Clin North Am1997;77:307. CrossRef

105. FalkensammerJ, OldenburgWA. Surgical and medical management of mesenteric ischemia. Curr Treat Options Cardiovasc Med2006;8:137. CrossRef

106. RivitzSM, GellerSC, HahnC, WaltmanAC. Treatment of acute mesenteric venous thrombosis with transjugular intramesenteric urokinase infusion. J Vasc Interv Radiol1995;6:219, discussion 224‐8. CrossRef

107. RosenMP, SheimanR. Transhepatic mechanical thrombectomy followed by infusion of TPA into the superior mesenteric artery to treat acute mesenteric vein thrombosis. J Vasc Interv Radiol2000;11(2 Pt 1):195. CrossRef

108. KimHS, PatraA, KhanJ, et al.Transhepatic catheter‐directed thrombectomy and thrombolysis of acute superior mesenteric venous thrombosis. J Vasc Interv Radiol2005;16:1685. CrossRef

109. PaternoF, LongoWE. The etiology and pathogenesis of vascular disorders of the intestine. Radiol Clin North Am2008;46:877, v. CrossRef

110. WhiteCJ. Chronic mesenteric ischemia: diagnosis and management. Prog Cardiovasc Dis2011;54:36. CrossRef

111. AtkinsMD, KwolekCJ, LaMuragliaGM, et al.Surgical revascularization versus endovascular therapy for chronic mesenteric ischemia: a comparative experience. J Vasc Surg2007;45:1162. CrossRef

112. MateoRB, O'HaraPJ, HertzerNR, et al.Elective surgical treatment of symptomatic chronic mesenteric occlusive disease: early results and late outcomes. J Vasc Surg1999;29:821, discussion 832. CrossRef

113. SchaeferPJ, SchaeferFK, HinrichsenH, et al.Stent placement with the monorail technique for treatment of mesenteric artery stenosis. J Vasc Interv Radiol2006;17:637. CrossRef

114. BradburyAW, BrittendenJ, McBrideK, RuckleyCV. Mesenteric ischaemia: a multidisciplinary approach. Br J Surg1995;82:1446. CrossRef

115. LoffroyR, GuiuB, CercueilJP, KrauséD. Chronic mesenteric ischemia: efficacy and outcome of endovascular therapy. Abdom Imaging2010;35:306. CrossRef

116. SheeranSR, MurphyTP, KhwajaA, et al.Stent placement for treatment of mesenteric artery stenoses or occlusions. J Vasc Interv Radiol1999;10:861. CrossRef

117. BrownDJ, SchermerhornML, PowellRJ, et al.Mesenteric stenting for chronic mesenteric ischemia. J Vasc Surg2005;42:268. CrossRef

118. ChangRW, ChangJB, LongoWE. Update in management of mesenteric ischemia. World J Gastroenterol2006;12:3243.

119. BelliAM, MarkoseG, MorganR. The role of interventional radiology in the management of abdominal visceral artery aneurysms. Cardiovasc Intervent Radiol2012;35:234. CrossRef

120. HossainA, ReisED, DaveSP, et al.Visceral artery aneurysms: experience in a tertiary‐care center. Am Surg2001;67:432.

121. ChiesaR, AstoreD, GuzzoG, et al.Visceral artery aneurysms. Ann Vasc Surg2005;19:42. CrossRef

122. SessaC, TinelliG, PorcuP, et al.Treatment of visceral artery aneurysms: description of a retrospective series of 42 aneurysms in 34 patients. Ann Vasc Surg2004;18:695. CrossRef

123. MessinaLM, ShanleyCJ. Visceral artery aneurysms. Surg Clin North Am1997;77:425. CrossRef

124. ShanleyCJ, ShahNL, MessinaLM. Common splanchnic artery aneurysms: splenic, hepatic, and celiac. Ann Vasc Surg1996;10:315. CrossRef

125. HuangYK, HsiehHC, TsaiFC, et al.Visceral artery aneurysm: risk factor analysis and therapeutic opinion. Eur J Vasc Endovasc Surg2007;33:293. CrossRef

126. TulsyanN, KashyapVS, GreenbergRK, et al.The endovascular management of visceral artery aneurysms and pseudoaneurysms. J Vasc Surg2007;45:276. CrossRef

127. SachdevU, BarilDT, EllozySH, et al.Management of aneurysms involving branches of the celiac and superior mesenteric arteries: a comparison of surgical and endovascular therapy. J Vasc Surg2006;44:718. CrossRef

128. RossiM, RebonatoA, GrecoL, et al. Endovascular exclusion of visceral artery aneurysms with stent‐grafts: technique and long‐term follow‐up. Cardiovasc Intervent Radiol2008;31:36. CrossRef

129. SuzukiK, TachiY, ItoS, et al.Endovascular management of ruptured pancreaticoduodenal artery aneurysms associated with celiac axis stenosis. Cardiovasc Intervent Radiol2008;31:1082. CrossRef

130. MissalME, RobinsonJA, TatumRW. Inferior vena cava obstruction: clinical manifestations, diagnostic methods, and related problems. Ann Intern Med1965;62:133. CrossRef

131. HarrisRD. The etiology of inferior vena caval obstruction and compression. CRC Crit Rev Clin Radiol Nucl Med1976;8:57.

132. ValjiK. Vascular and Interventional Radiology, 2nd ed, Hardcover. Saunders; 2006. June 2, 2006.

133. SiegfriedMS, RochesterD, BernsteinJR, et al.Diagnosis of inferior vena cava anomalies by computerized tomography. Comput Radiol1983;7:119. CrossRef

134. HansenME, MillerGL3rd, StarksKC. Pulse‐spray thrombolysis of inferior vena cava thrombosis complicating filter placement. Cardiovasc Intervent Radiol1994;17:38. CrossRef

135. WilsonJJ, BalsysA, NewmanH, et al.IVC thrombosis: successful treatment with low dose streptokinase. J Cardiovasc Surg (Torino)1992;33:109.

136. CharnsangavejC, CarrascoCH, WallaceS, et al.Stenosis of the vena cava: preliminary assessment of treatment with expandable metallic stents. Radiology1986;161:295. CrossRef

137. NazarianGK, AustinWR, WegrynSA, et al.Venous recanalization by metallic stents after failure of balloon angioplasty or surgery: four‐year experience. Cardiovasc Intervent Radiol1996;19:227. CrossRef

138. CarrascoCH, CharnsangavejC, WrightKC, et al.Use of the Gianturco self‐expanding stent in stenoses of the superior and inferior venae cavae. J Vasc Interv Radiol1992;3:409. CrossRef

139. IrvingJD, DondelingerRF, ReidyJF, et al.Gianturco self‐expanding stents: clinical experience in the vena cava and large veins. Cardiovasc Intervent Radiol1992;15:328. CrossRef

140. ElsonJD, BeckerGJ, WholeyMH, et al.Vena caval and central venous stenoses: management with palmaz balloon‐expandable intraluminal stents. J Vasc Interv Radiol1991;2:215. CrossRef

141. SarosiekS, CrowtherM, SloanJM. Indications, complications, and management of inferior vena cava filters: the experience in 952 patients at an academic hospital with a level I trauma center. JAMA Intern Med2013;173:513. CrossRef

142. RazaviMK, HanschEC, KeeST, et al.Chronically occluded inferior venae cavae: endovascular treatment. Radiology2000;214:133. CrossRef

143. ProtackCD, BakkenAM, PatelN, et al.Long‐term outcomes of catheter directed thrombolysis for lower extremity deep venous thrombosis without prophylactic inferior vena cava filter placement. J Vasc Surg2007;45:992, discussion 997. CrossRef

144. HirshJ, GuyattG, AlbersGW, et al.Antithrombotic and thrombolytic therapy: American College of Chest Physicians Evidence‐Based Clinical Practice Guidelines (8th Edition). Chest2008;133(6 Suppl):110S. CrossRef

145. WangX, ChenZ, CaiQ. Catheter‐directed thrombolysis for double inferior vena cava with deep venous thrombosis: a case report and literature review. Phlebology2013;●●:●●.

146. KolbelT, GottsäterA, KühmeT, et al.Endovascular treatment of venous occlusive disease. Ann Vasc Dis2008;1:91. CrossRef

147. SrinivasBC, SinghAP, NageshCM, et al.Transjugular approach for successful recanalization and stenting for inferior vena cava stenosis. Cardiovasc Interv Ther2013;28:318. CrossRef

148. SatoY, InabaY, YamauraH, et al.Malignant inferior vena cava syndrome and congestive hepatic failure treated by venous stent placement. J Vasc Interv Radiol2012;23:1377. CrossRef

149. OudkerkM, HeystratenFM, StoterG. Stenting in malignant vena caval obstruction. Cancer1993;71:142. CrossRef

150. MurphySL, XuJ, KochanekKD. Final data for 2010. Natl Vital Stat Rep2013;8:●●.

151. AsraniSK, KamathPS. Natural history of cirrhosis. Curr Gastroenterol Rep2013;15:308. CrossRef

152. BerzigottiA, SeijoS, ReverterE, et al.Assessing portal hypertension in liver diseases. Expert Rev Gastroenterol Hepatol2013;7:141. CrossRef

153. Garcia‐TsaoG, GroszmannRJ, FisherRL, et al.Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology1985;5:419. CrossRef

154. LebrecD, BatailleC, BercoffE, et al.Hemodynamic changes in patients with portal venous obstruction. Hepatology1983;3:550. CrossRef

155. BoschJ, AbraldesJG, BerzigottiA, et al.The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol2009;6:573. CrossRef

156. RichterGM, PalmazJC, NöldgeG, et al.The transjugular intrahepatic portosystemic stent‐shunt. A new nonsurgical percutaneous method. Radiologe1989;29:406.

157. CorbettC, MangatK, OlliffS, et al.The role of transjugular intrahepatic portosystemic stent‐shunt (TIPSS) in the management of variceal hemorrhage. Liver Int2012;32:1493. CrossRef

158. FidelmanN, KwanSW, LaBergeJM, et al.The transjugular intrahepatic portosystemic shunt: an update. AJR Am J Roentgenol2012;199:746. CrossRef

159. BoyerTD, HaskalZJ, American Association for the Study of Liver Diseases. The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the Management of Portal Hypertension: update 2009. Hepatology2010;51:306. CrossRef

160. RossleM. TIPS: 25 years later. J Hepatol2013;59:1081. CrossRef

161. SalernoF, CammàC, EneaM, et al.Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta‐analysis of individual patient data. Gastroenterology2007;133:825. CrossRef

162. BartonRE, RöschJ, SaxonRR, et al.TIPS: Short‐ and long‐term results: a survey of 1750 patients. Semin Interv Radiol1995;12:364. CrossRef

163. HaskalZJ, MartinL, CardellaJF, et al.Quality improvement guidelines for transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol2003;14(9 Pt 2):S265. CrossRef

164. SalernoF, MerliM, CazzanigaM, et al.MELD score is better than Child‐Pugh score in predicting 3‐month survival of patients undergoing transjugular intrahepatic portosystemic shunt. J Hepatol2002;36:494. CrossRef

165. SchepkeM, RothF, FimmersR, et al.Comparison of MELD, Child‐Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting. Am J Gastroenterol2003;98:1167. CrossRef

166. PanJJ, ChenC, CaridiJG, et al.Factors predicting survival after transjugular intrahepatic portosystemic shunt creation: 15 years' experience from a single tertiary medical center. J Vasc Interv Radiol2008;19:1576. CrossRef

167. Harrod‐KimP, SaadWE, WaldmanD. Predictors of early mortality after transjugular intrahepatic portosystemic shunt creation for the treatment of refractory ascites. J Vasc Interv Radiol2006;17:1605. CrossRef

168. Garcia‐PaganJC, CacaK, BureauC, et al.Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med2010;362:2370. CrossRef

169. JalanR, RedheadDN, AllanPL, et al.Prospective evaluation of haematological alterations following the transjugular intrahepatic portosystemic stent‐shunt (TIPSS). Eur J Gastroenterol Hepatol1996;8:381. CrossRef

170. DarcyM. Evaluation and management of transjugular intrahepatic portosystemic shunts. AJR Am J Roentgenol2012;199:730. CrossRef

171. ParvinianA, OmeneBO, BuiJT, et al.Angiographic patterns of transjugular intrahepatic portosystemic shunt dysfunction and interventional approaches to shunt revision. J Clin Imaging Sci2013;3:19. CrossRef

172. CuraM, HaskalZ, LoperaJ. Diagnostic and interventional radiology for Budd‐Chiari syndrome. Radiographics2009;29:669. CrossRef

173. FerralH, BehrensG, LoperaJ. Budd‐Chiari syndrome. AJR Am J Roentgenol2012;199:737. CrossRef

174. BeckettD, OlliffS. Interventional radiology in the management of Budd Chiari syndrome. Cardiovasc Intervent Radiol2008;31:839. CrossRef

175. CwikielW. Interventional procedures involving portal vein circulation: a review. Acta Radiol2006;47:145. CrossRef

176. ChawlaY, DusejaA, DhimanRK. Review article: the modern management of portal vein thrombosis. Aliment Pharmacol Ther2009;30:881. CrossRef

177. ThomasRM, AhmadSA. Management of acute post‐operative portal venous thrombosis. J Gastrointest Surg2010;14:570. CrossRef

178. HollingsheadM, BurkeCT, MauroMA, et al.Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis. J Vasc Interv Radiol2005;16:651. CrossRef

179. PetersenB, UchidaBT, TimmermansH, et al.Intravascular US‐guided direct intrahepatic portacaval shunt with a PTFE‐covered stent‐graft: feasibility study in swine and initial clinical results. J Vasc Interv Radiol2001;12:475. CrossRef

180. PetersenB, BinkertC. Intravascular ultrasound‐guided direct intrahepatic portacaval shunt: midterm follow‐up. J Vasc Interv Radiol2004;15:927. CrossRef

181. PetersenBD, ClarkTW. Direct intrahepatic portocaval shunt. Tech Vasc Interv Radiol2008;11:230. CrossRef

182. HarbinWP, MuellerPR, FerrucciJTJr. Transhepatic cholangiography: complicatons and use patterns of the fine‐needle technique: a multi‐institutional survey. Radiology1980;135:15. CrossRef

183. MuellerPR, HarbinWP, FerrucciJTJr, et al.Fine‐needle transhepatic cholangiography: reflections after 450 cases. AJR Am J Roentgenol1981;136:85. CrossRef

184. MuellerPR, vanSonnenbergE, SimeoneJF. Fine‐needle transhepatic cholangiography. Indications and usefulness. Ann Intern Med1982;97:567. CrossRef

185. TeplickSK, FlickP, BrandonJC. Transhepatic cholangiography in patients with suspected biliary disease and nondilated intrahepatic bile ducts. Gastrointest Radiol1991;16:193. CrossRef

186. CraigDA, MacCartyRL, WiesnerRH, et al.Primary sclerosing cholangitis: value of cholangiography in determining the prognosis. AJR Am J Roentgenol1991;157:959. CrossRef

187. SaadWE, WallaceMJ, WojakJC, et al.Quality improvement guidelines for percutaneous transhepatic cholangiography, biliary drainage, and percutaneous cholecystostomy. J Vasc Interv Radiol2010;21:789. CrossRef

188. IaconoC, RuzzenenteA, CampagnaroT, et al.Role of preoperative biliary drainage in jaundiced patients who are candidates for pancreatoduodenectomy or hepatic resection: highlights and drawbacks. Ann Surg2013;257:191. CrossRef

189. SewnathME, KarstenTM, PrinsMH, et al.A meta‐analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. Ann Surg2002;236:17. CrossRef

190. FangY, GurusamyKS, WangQ, et al.Pre‐operative biliary drainage for obstructive jaundice. Cochrane Database Syst Rev2012;(9):CD005444.

191. ThorntonRH, UlrichR, HsuM, et al.Outcomes of patients undergoing percutaneous biliary drainage to reduce bilirubin for administration of chemotherapy. J Vasc Interv Radiol2012;23:89. CrossRef

192. TappingCR, ByassOR, CastJE. Percutaneous transhepatic biliary drainage (PTBD) with or without stenting‐complications, re‐stent rate and a new risk stratification score. Eur Radiol2011;21:1948. CrossRef

193. van DeldenOM, LamerisJS. Percutaneous drainage and stenting for palliation of malignant bile duct obstruction. Eur Radiol2008;18:448. CrossRef

194. DavidsPH, GroenAK, RauwsEA, et al.Randomised trial of self‐expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet1992;340:1488. CrossRef

195. KnyrimK, WagnerHJ, PauschJ, et al.A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct. Endoscopy1993;25:207. CrossRef

196. MossAC, MorrisE, LeydenJ, et al.Do the benefits of metal stents justify the costs? A systematic review and meta‐analysis of trials comparing endoscopic stents for malignant biliary obstruction. Eur J Gastroenterol Hepatol2007;19:1119. CrossRef

197. IsayamaH, KomatsuY, TsujinoT, et al.A prospective randomised study of “covered” versus “uncovered” diamond stents for the management of distal malignant biliary obstruction. Gut2004;53:729. CrossRef

198. KrokidisM, FanelliF, OrgeraG, et al.Percutaneous palliation of pancreatic head cancer: randomized comparison of ePTFE/FEP‐covered versus uncovered nitinol biliary stents. Cardiovasc Intervent Radiol2011;34:352. CrossRef

199. KrokidisM, FanelliF, OrgeraG, et al.Percutaneous treatment of malignant jaundice due to extrahepatic cholangiocarcinoma: covered Viabil stent versus uncovered Wallstents. Cardiovasc Intervent Radiol2010;33:97. CrossRef

200. TelfordJJ, Carr‐LockeDL, BaronTH, et al.A randomized trial comparing uncovered and partially covered self‐expandable metal stents in the palliation of distal malignant biliary obstruction. Gastrointest Endosc2010;72:907. CrossRef

201. KullmanE, FrozanporF, SoderlundC, et al.Covered versus uncovered self‐expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study. Gastrointest Endosc2010;72:915. CrossRef

202. WalterT, HoCS, HorganAM, et al.Endoscopic or percutaneous biliary drainage for Klatskin tumors?J Vasc Interv Radiol2013;24:113. CrossRef

203. RerknimitrR, AngsuwatcharakonP, Ratanachu‐ekT, et al.Asia‐Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma. J Gastroenterol Hepatol2013;28:593. CrossRef

204. PinolV, CastellsA, BordasJM, et al.Percutaneous self‐expanding metal stents versus endoscopic polyethylene endoprostheses for treating malignant biliary obstruction: randomized clinical trial. Radiology2002;225:27. CrossRef

205. LammerJ, NeumayerK. Biliary drainage endoprostheses: experience with 201 placements. Radiology1986;159:625. CrossRef

206. LamerisJS, StokerJ, NijsHG, et al.Malignant biliary obstruction: percutaneous use of self‐expandable stents. Radiology1991;179:703. CrossRef

207. RieberA, BrambsHJ. Metallic stents in malignant biliary obstruction. Cardiovasc Intervent Radiol1997;20:43. CrossRef

208. SiriwardanaHP, SiriwardenaAK. Systematic appraisal of the role of metallic endobiliary stents in the treatment of benign bile duct stricture. Ann Surg2005;242:10. CrossRef

209. LillemoeKD, PittHA, CameronJL. Postoperative bile duct strictures. Surg Clin North Am1990;70:1355.

210. BergmanJJ, BurgemeisterL, BrunoMJ, et al.Long‐term follow‐up after biliary stent placement for postoperative bile duct stenosis. Gastrointest Endosc2001;54:154. CrossRef

211. AtarE, BacharGN, BartalG, et al.Use of peripheral cutting balloon in the management of resistant benign ureteral and biliary strictures. J Vasc Interv Radiol2005;16(2 Pt 1):241. CrossRef

212. AtarE, BacharGN, BartalG, et al.Peripheral cutting balloon in the management of resistant benign ureteral and biliary strictures: long‐term results. Diagn Interv Radiol2007;13:39.

213. CitronSJ, MartinLG. Benign biliary strictures: treatment with percutaneous cholangioplasty. Radiology1991;178:339. CrossRef

214. MuellerPR, van SonnenbergE, FerrucciJTJr, et al.Biliary stricture dilatation: multicenter review of clinical management in 73 patients. Radiology1986;160:17. CrossRef

215. ZuidemaGD, CameronJL, SitzmannJV, et al.Percutaneous transhepatic management of complex biliary problems. Ann Surg1983;197:584. CrossRef

216. GallacherDJ, KadirS, KaufmanSL, et al.Nonoperative management of benign postoperative biliary strictures. Radiology1985;156:625. CrossRef

217. MisraS, MeltonGB, GeschwindJF, et al.Percutaneous management of bile duct strictures and injuries associated with laparoscopic cholecystectomy: a decade of experience. J Am Coll Surg2004;198:218. CrossRef

218. MaccioniF, RossiM, SalvatoriFM, et al.Metallic stents in benign biliary strictures: three‐year follow‐up. Cardiovasc Intervent Radiol1992;15:360. CrossRef

219. GwonDI, ShimHJ, KwakBK. Retrievable biliary stent‐graft in the treatment of benign biliary strictures. J Vasc Interv Radiol2008;19:1328. CrossRef

220. CostamagnaG, TringaliA, MutignaniM, et al.Endotherapy of postoperative biliary strictures with multiple stents: results after more than 10 years of follow‐up. Gastrointest Endosc2010;72:551. CrossRef

221. KahalehM, BehmB, ClarkeBW, et al.Temporary placement of covered self‐expandable metal stents in benign biliary strictures: a new paradigm? (with video). Gastrointest Endosc2008;67:446. CrossRef

222. LivingstonEH, RegeRV. Technical complications are rising as common duct exploration is becoming rare. J Am Coll Surg2005;201:426. CrossRef

223. NeuhausH. Intrahepatic stones: the percutaneous approach. Can J Gastroenterol1999;13:467.

224. HatzidakisA, KrokidisM, GourtsoyiannisN. Percutaneous removal of biliary calculi. Cardiovasc Intervent Radiol2009;32:1130. CrossRef

225. KimYH, KimYJ, ShinTB. Fluoroscopy‐guided percutaneous gallstone removal using a 12‐Fr sheath in high‐risk surgical patients with acute cholecystitis. Korean J Radiol2011;12:210. CrossRef

226. BurtonKE, PicusD, HicksME, et al.Fragmentation of biliary calculi in 71 patients by use of intracorporeal electrohydraulic lithotripsy. J Vasc Interv Radiol1993;4:251. CrossRef

227. PicusD, HicksME, DarcyMD, et al.Percutaneous cholecystolithotomy: analysis of results and complications in 58 consecutive patients. Radiology1992;183:779. CrossRef

228. ZouYP, DuJD, LiWM, et al.Gallstone recurrence after successful percutaneous cholecystolithotomy: a 10‐year follow‐up of 439 cases. Hepatobiliary Pancreat Dis Int2007;6:199.

229. McDermottVG, ArgerP, CopeC. Gallstone recurrence and gallbladder function following percutaneous cholecystolithotomy. J Vasc Interv Radiol1994;5:473. CrossRef

230. BerkmanWA, BishopAF, PalagalloGL, et al.Transhepatic balloon dilation of the distal common bile duct and ampulla of Vater for removal of calculi. Radiology1988;167:453. CrossRef

231. Garcia‐GarciaL, LanciegoC. Percutaneous treatment of biliary stones: sphincteroplasty and occlusion balloon for the clearance of bile duct calculi. AJR Am J Roentgenol2004;182:663. CrossRef

232. ParkYS, KimJH, ChoiYW, et al.Percutaneous treatment of extrahepatic bile duct stones assisted by balloon sphincteroplasty and occlusion balloon. Korean J Radiol2005;6:235. CrossRef

233. DawsonSL, MuellerPR, LeeMJ, et al.Treatment of bile duct stones by laser lithotripsy: results in 12 patients. AJR Am J Roentgenol1992;158:1007. CrossRef

234. NeuhausH, HoffmannW, ZillingerC, et al.Laser lithotripsy of difficult bile duct stones under direct visual control. Gut1993;34:415. CrossRef

235. HarrisVJ, ShermanS, TrerotolaSO, et al.Complex biliary stones: treatment with a small choledochoscope and laser lithotripsy. Radiology1996;199:71. CrossRef

236. RaunestJ, ImhofM, RauenU, et al.Acute cholecystitis: a complication in severely injured intensive care patients. J Trauma1992;32:433. CrossRef

237. LittleMW, BriggsJH, TappingCR, et al.Percutaneous cholecystostomy: the radiologist's role in treating acute cholecystitis. Clin Radiol2013;68:654. CrossRef

238. GinatD, SaadWE. Cholecystostomy and transcholecystic biliary access. Tech Vasc Interv Radiol2008;11:2. CrossRef

239. vanSonnenbergE, D'AgostinoHB, GoodacreBW, et al.Percutaneous gallbladder puncture and cholecystostomy: results, complications, and caveats for safety. Radiology1992;183:167. CrossRef

240. ChungYH, ChoiER, KimKM, et al.Can percutaneous cholecystostomy be a definitive management for acute acalculous cholecystitis?J Clin Gastroenterol2012;46:216. CrossRef

241. DewhurstC, KaneRA, MhuircheartaighJN, et al.Complication rate of ultrasound‐guided percutaneous cholecystostomy in patients with coagulopathy. AJR Am J Roentgenol2012;199:W753. CrossRef

242. DavisCA, LandercasperJ, GundersenLH, et al.Effective use of percutaneous cholecystostomy in high‐risk surgical patients: techniques, tube management, and results. Arch Surg1999;134:727, discussion 731‐2. CrossRef

243. SmithTJ, ManskeJG, MathiasonMA, et al.Changing trends and outcomes in the use of percutaneous cholecystostomy tubes for acute cholecystitis. Ann Surg2013;257:1112. CrossRef

244. WinbladhA, GullstrandP, SvanvikJ, et al.Systematic review of cholecystostomy as a treatment option in acute cholecystitis. HPB (Oxford)2009;11:183. CrossRef

245. KochM, GardenOJ, PadburyR, et al.Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery2011;149:680. CrossRef

246. ErdoganD, BuschOR, van DeldenOM, et al.Incidence and management of bile leakage after partial liver resection. Dig Surg2008;25:60. CrossRef

247. de CastroSM, KuhlmannKF, BuschOR, et al.Incidence and management of biliary leakage after hepaticojejunostomy. J Gastrointest Surg2005;9:1163, discussion 1171‐3. CrossRef

248. HollandsMJ, LittleJM. Post‐traumatic bile fistulae. J Trauma1991;31:117. CrossRef

249. SharmaBC, MishraSR, KumarR, et al.Endoscopic management of bile leaks after blunt abdominal trauma. J Gastroenterol Hepatol2009;24:757. CrossRef

250. ErnstO, SergentG, MizrahiD, et al.Biliary leaks: treatment by means of percutaneous transhepatic biliary drainage. Radiology1999;211:345. CrossRef

251. FunakiB, ZaleskiGX, StrausCA, et al.Percutaneous biliary drainage in patients with nondilated intrahepatic bile ducts. AJR Am J Roentgenol1999;173:1541. CrossRef

252. DiSarioJA, BaskinWN, BrownRD, et al.Endoscopic approaches to enteral nutritional support. Gastrointest Endosc2002;55:901. CrossRef

253. PreshawRM. A percutaneous method for inserting a feeding gastrostomy tube. Surg Gynecol Obstet1981;152:658.

254. HeylandDK, DroverJW, MacDonaldS, et al.Effect of postpyloric feeding on gastroesophageal regurgitation and pulmonary microaspiration: results of a randomized controlled trial. Crit Care Med2001;29:1495. CrossRef

255. MarikPE, ZalogaGP. Gastric versus post‐pyloric feeding: a systematic review. Crit Care2003;7:R46. CrossRef

256. HsuCW, SunSF, LinSL, et al.Duodenal versus gastric feeding in medical intensive care unit patients: a prospective, randomized, clinical study. Crit Care Med2009;37:1866. CrossRef

257. GassasA, KennedyJ, GreenG, et al.Risk of ventriculoperitoneal shunt infections due to gastrostomy feeding tube insertion in pediatric patients with brain tumors. Pediatr Neurosurg2006;42:95. CrossRef

258. WollmanB, D'AgostinoHB, Walus‐WigleJR, et al.Radiologic, endoscopic, and surgical gastrostomy: an institutional evaluation and meta‐analysis of the literature. Radiology1995;197:699. CrossRef

259. MuellerPR, vanSonnenbergE. Interventional radiology in the chest and abdomen. N Engl J Med1990;322:1364. CrossRef

260. SmithEH. Complications of percutaneous abdominal fine‐needle biopsy. Review. Radiology1991;178:253. CrossRef

261. KalambokisG, ManousouP, VibhakornS, et al.Transjugular liver biopsy–indications, adequacy, quality of specimens, and complications–a systematic review. J Hepatol2007;47:284. CrossRef

262. MammenT, KeshavaSN, EapenCE, et al.Transjugular liver biopsy: a retrospective analysis of 601 cases. J Vasc Interv Radiol2008;19:351. CrossRef

263. DellingerRP. The Surviving Sepsis Campaign: 2013 and beyond. Chin Med J (Engl)2013;126:1803.

264. van SonnenbergE, WittichGR, GoodacreBW, et al.Percutaneous abscess drainage: update. World J Surg2001;25:362, discussion 370‐2. CrossRef

265. GeeMS, KimJY, GervaisDA, et al.Management of abdominal and pelvic abscesses that persist despite satisfactory percutaneous drainage catheter placement. AJR Am J Roentgenol2010;194:815. CrossRef

266. LangEK, SpringerRM, GloriosoLW3rd, et al.Abdominal abscess drainage under radiologic guidance: causes of failure. Radiology1986;159:329. CrossRef

267. WallaceMJ, ChinKW, FletcherTB, et al.Quality improvement guidelines for percutaneous drainage/aspiration of abscess and fluid collections. J Vasc Interv Radiol2010;21:431. CrossRef

268. HoganMJ, MarshalleckFE, SidhuMK, et al.Quality improvement guidelines for pediatric abscess and fluid drainage. J Vasc Interv Radiol2012;23:1397. CrossRef